Parkside Financial Bank & Trust’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63K Buy
34
+3
+10% +$363 ﹤0.01% 1999
2026
Q1
$5.07K Sell
31
-2
-6% -$307 ﹤0.01% 1816
2025
Q4
$5.74K Buy
33
+18
+120% +$3.29K ﹤0.01% 1758
2025
Q3
$2.16K Sell
15
-8
-35% -$980 ﹤0.01% 1993
2025
Q2
$2.29K Sell
23
-101
-81% -$7.72K ﹤0.01% 1957
2025
Q1
$9.46K Buy
+124
New +$9.48K ﹤0.01% 1422

Other funds holding INSM

Parkside Financial Bank & Trust's INSM Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Insmed (INSM) stake by 9.7% in Q2 2026, buying an estimated $363 and bringing the position to 34 shares worth $3.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

Parkside Financial Bank & Trust first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.46K in Q1 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Parkside Financial Bank & Trust held 34 shares of Insmed worth $3.63K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 3 Insmed shares in Q2 2026, an estimated $363.
  • Insmed made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1999 holding.
  • Parkside Financial Bank & Trust first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
  • Parkside Financial Bank & Trust's Insmed position peaked at $9.46K in Q1 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.